FTC Proposes Amendments to the Premerger Notification Rules Related to the Transfer of Exclusive Patent Rights in the Pharmaceutical Industry
Client Memorandum

Created date

On August 13, 2012, the Federal Trade Commission published a notice of proposed rulemaking, setting forth proposed amendments to the Hart-Scott-Rodino Premerger Notification Rules aimed at clarifying – and effectively expanding – the scope of transactions involving the transfer of rights to a patent in the pharmaceutical, biologics, and medicine manufacturing industries that may be subject to the notification and waiting period requirements of the HSR Act.